Visão geral da empresa Spectral Medical
1 escritórioLocalizações
When endotoxins seep in and sepsis sets in Spectral Diagnostics is there to help. The company's lead product is a endotoxin activity diagnostic product used to identify patients at risk of developing sepsis (infection). The company is using the diagnostic test to create a companion sepsis treatment device, Toraymyxin, which is in late-stage clinical trials to gain FDA clearance. Toraymyxin, which works to remove endotoxins from patients' blood, is already available in international markets. The company also provides biochemicals, such as polypeptides and other reagents, used in diagnostic procedures.
